TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat

Kidney International

Volumn 58, Issue 3, 2000, Pages 1186-1201

  Duymelinck, C ^a   Dauwe, S E H ^a   De Greef, K E J ^a   Ysebaert, D K ^a   Verpooten, G A ^a   De Broe, M E ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apoptosis; Fibrosis; Interstitial cells; Macrophages; Neutrophils; Scarring; smooth muscle actin

Indexed keywords

ALPHA ACTIN; EOSIN; HEMATOXYLIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; KIDNEY FIBROSIS; LEYDIG CELL; MACROPHAGE; MALE; MITOSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; URETER OBSTRUCTION;

EID: 0033863333     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00274.x     Document Type: Article

References (53)

1. Development of human fetal kidney in obstructive nephropathy: Correlations with ultrasonography and urine biochemistry
2. Cell apoptosis and proliferation in experimental chronic obstructive uropathy
3. Effects of urinary tract obstruction on glomerular filtration rate and renal blood flow
4. Pathophysiology of obstructive nephropathy
5. Effect of leukocyte depletion on the function of the postobstructed kidney in the rat
6. Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2 and -3 in experimental hydronephrosis
7. Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model
8. Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy
9. Experimental diffuse interstitial renal fibrosis: A biochemical approach
10. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions
11. Delayed treatment with enalapril halts interstitial fibrosis in rats with obstructive nephropathy
12. The plasminogen activator/plasmin system
13. Evaluation of the LOGIC system for the rapid identification of the Enterobacteriaceae in the clinical microbiology laboratory
14. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis
15. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy
16. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3
17. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis
18. Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase 1 (TIMP-1), amino acid comparison with other TIMPs, and gene expression in rat tissues
19. Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells
20. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis
21. Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia
22. Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal anti-body-based enzyme-linked immunosorbent assay
23. Cholesterol feeding accentuates the cyclosporine-induced elevation of real plasminogen activator inhibitor type 1
24. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
25. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
26. Macrophages and progressive renal disease in experimental hydronephrosis
27. Chronic obstructive uropathy in severe combined immunodeficient (SCID) mice: Lymphocyte infiltration is not required for progressive tubulointerstitial iniury
28. Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes
29. Inter-regulated balance between gelatinases and tissue inhibitor (TIMP-1) in isolated human glomeruli
30. Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney
31. Renal microcirculation and tissue damage during acute ureteral obstruction in the rats: Effect of saline infusion, indomethacin and radiocontrast
32. Eicosanoid production by isolated glomeruli of rats with unilateral ureteral obstruction
33. Unilateral obstructive nephropathy in the rabbit. I. Early morphological, physiological, and histochemical changes
34. Genesis of renal tubular atrophy in experimental hydronephrosis in the rat
35. Pyelonephritis. I. Observations on the course of chronic non-obstructed enterococcal infection in the kidney of the rat
36. Morphological and immunohistological study of pyelonephritis in rats by various bacteria and fungi. Special reference to inflammatory changes and localization of antigen
37. Pyelonephritis: The relationship between infection, renal scarring and antimicrobial therapy
38. Relationship between neutrophil-mediated oxidative injury during acute experimental pyelonephritis and chronic renal scarring
39. Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis
40. Effect of proteinase K on the sensitivity and specificity of in situ end labelling for apoptosis in the rat kidney (chapt 4), in Apoptosis and Re-epithelialization in the Rat Kidney After Toxic Injury
41. Cell shape-dependent pathway of plasminogen activator inhibitor type-l gene expression requires cytoskeletal reorganization
42. Interstitial inflammation and fibrosis in obstructive nephropathy; the role of ACE inhibitors and nitric oxide
43. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring
44. Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction
45. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice
46. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy
47. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
48. Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition
49. Tubular epithelialmyofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats
50. Biology of disease. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations
51. Postnatal maturation of renal cortical peritubular fibroblasts in the rat
52. Cellular apoptosis and proliferation in experimental renal fibrosis
53. Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of α-smooth muscle actin